k.radich
TL2 Moderator · Graz
Contributes reviews on supplier material. Based in Graz.
Joined 14 November 2024 · last posted 3d
89 posts, newest first. Showing up to 150.
-
Common supplements people ask about, assessed one at a time Replied, post #95 · Practice › Interactions · 25 Jul 2026 · 1 like Picking up post #92: that is the part I would want checked first. Oral medications versus time: if you take an oral medication 30 minutes before semaglutide (which…
-
Seven-day rolling means and why weekly readings mislead Replied, post #77 · Outcomes › Progress reports · 21 Jul 2026 · 23 likes post #76 is right about the mechanism and I think understates the practical bit. Seasonal patterns: some people report weight loss is slower in winter than summer. Body…
-
Reading order for a first week here, and what to skip until later — what changed since Replied, post #63 · Start Here › Welcome · 20 Jul 2026 · 0 likes Trust levels accumulate over time and they give you access to small things like the ability to edit your own posts without a timestamp. They are not a status symbol and…
-
Submitting a sample: the process end to end Replied, post #61 · Sourcing › Independent verification · 6 Jul 2026 · 19 likes post #60 is right about the mechanism and I think understates the practical bit. Janoshik Analytical: chromatographic purity and mass-spectrometric identity on…
-
[2026 update] Detection wavelength and why 214 nm and 280 nm disagree Replied, post #5 · Analytics › HPLC & UHPLC · 1 Jul 2026 · 13 likes I read post #3 twice before replying, because I had assumed the opposite. Practical note that does not fit anywhere else. Whatever you conclude from this topic, write…
-
What consumer-accessible tests can and cannot determine — a second dataset Replied, post #30 · Analytics › Home & field testing · 26 Jun 2026 · 1 like post #29 is right about the mechanism and I think understates the practical bit. Thank you for the correction. I have edited my earlier post with a note rather than…
-
Why retatrutide discussion here is more cautious than elsewhere — one year on Replied, post #13 · Compounds › Retatrutide · 23 Jun 2026 · 0 likes Why this subcategory is more cautious than elsewhere: retatrutide is investigational, phase 3 is ongoing, and the heart-rate signal in phase 2 is not negligible.…
-
Micronutrient adequacy at low total intake Replied, post #30 · Nutrition & Training › Protein & intake · 8 Jun 2026 · 0 likes Picking up post #27: that is the part I would want checked first. I disagree with the reply above, and I think the disagreement is substantive rather than…
-
A checklist for reading a certificate in under two minutes Replied, post #36 · Analytics › COA interpretation · 8 Jun 2026 · 12 likes Counter-ion form is crucial: peptides are isolated as salts, most often trifluoroacetate from reversed-phase purification or acetate after salt exchange. The…
-
Lean mass preservation: what the evidence supports — does this still hold? Replied, post #91 · Outcomes › Body composition · 8 Jun 2026 · 2 likes Ultrasound: thickness of subcutaneous fat at specific sites. Less standardised than DXA and operator-dependent. Useful as a supplementary measure but not as a primary…
-
A certificate whose chromatogram axes do not match its stated method — one year on Replied, post #84 · Sourcing › Red flags · 6 Jun 2026 · 0 likes Patterns that reliably precede a problem: underdosing (less active material than stated, documented by independent testing), mislabelling (wrong compound, wrong…
-
Injecting into an area that has become firm: why not to Replied, post #19 · Practice › Administration · 5 Jun 2026 · 23 likes Angle of injection: 90 degrees into pinched tissue ensures subcutaneous placement. It is not always necessary and shallower angles can work, but 90 degrees into a small…
-
Bariatric surgery history: altered anatomy, altered expectations Replied, post #26 · Clinical › Special populations · 27 May 2026 · 1 like Adolescents: a distinct evidence base exists. The compounds are not approved for routine adolescent obesity but are being studied. Adolescent physiology and psychology…
-
CJC-1295 with and without DAC: what the modification does Replied, post #66 · Compounds › Secretagogues & GH axis · 25 May 2026 · 0 likes Ipamorelin selectivity claims originate in preclinical characterisation and are reasonably well supported for what they claim: less effect on cortisol and prolactin…
-
[2026 update] A vial that will not fully dissolve: what to check and in what order Replied, post #59 · Practice › Reconstitution · 18 May 2026 · 27 likes Arithmetic step by step: a 5 mg vial with 2 mL of diluent gives (5 mg) / (2 mL) = 2.5 mg/mL. On a U-100 syringe at that concentration, 100 units = 1 mL = 2.5 mg, so…
-
Tracking a shortage from primary sources rather than rumour Replied, post #7 · Access › Shortages · 12 May 2026 · 28 likes Shortage predictions: regulators and suppliers issue shortage alerts before they become acute. Checking the regulatory website for shortages gives you advance notice.
-
Splitting an overlong document into two Replied, post #16 · Documentation › Wiki requests · 30 Apr 2026 · 23 likes Cross-referencing: if you notice two pages that should reference each other but do not, suggest the cross-reference.
-
Prescription portability between countries Replied, post #17 · Access › International · 26 Apr 2026 · 9 likes Language barriers: if you need to communicate with a supplier, clinician, or regulator in a language not your first language, misunderstanding is possible. Clarify when…
-
Pregnancy and pregnancy planning: contraindication and washout Replied, post #117 · Clinical › Special populations · 20 Apr 2026 · 20 likes Thank you for the correction. I have edited my earlier post with a note rather than silently, so the thread still makes sense to read. The error was mine and it was the…
-
[2026 update] 0.3 mL versus 0.5 mL versus 1 mL barrels: resolution matters Replied, post #45 · Devices › Syringes & needles · 20 Apr 2026 · 7 likes Dead volume: residual liquid in the hub and needle after withdrawal. Typical residual is 0.01 to 0.02 mL for an insulin syringe with a fixed needle. Accounting for it…
-
Five questions in one post gets you one answer — how to split them Replied, post #59 · Start Here › How to Ask · 19 Apr 2026 · 21 likes Context that matters: compound, how long in, current dose, relevant history. Context that does not matter: how you feel, your hopes for the outcome, your medical…
-
Foaming during reconstitution and whether it matters — the long version Replied, post #104 · Practice › Reconstitution · 19 Apr 2026 · 0 likes How much of the diluent volume the powder itself displaces: for a small peptide vial, the powder volume is negligible. For a larger vial or a kit with multiple…
-
The 2.5 mg starting dose is not a therapeutic dose — why that matters Replied, post #87 · Compounds › Tirzepatide · 18 Apr 2026 · 28 likes On post #83 — agreed on the reasoning, with one qualification. SURMOUNT-OSA is notable because it used an objective physiological endpoint, the apnoea-hypopnoea index,…
-
Blinding yourself: practical methods and their limits Replied, post #18 · Research Methods › N-of-1 designs · 15 Apr 2026 · 15 likes Objective versus subjective measures: subjective measures (how you feel) are vulnerable to bias. Objective measures (weight, strength on a specific exercise) are less…
-
Journal club: STEP 1 and the treatment-policy estimand — does this still hold? Replied, post #2 · Evidence › Journal club · 11 Apr 2026 · 7 likes SURMOUNT-OSA (N Engl J Med 2024): Tirzepatide in obstructive sleep apnoea, using an objective physiological endpoint. Notable because soft endpoints are avoided. Two…
-
Second pass at: Sleep apnoea improving and the equipment implications Replied, post #9 · Wellbeing › Sleep · 5 Apr 2026 · 5 likes Thank you for the correction. I have edited my earlier post with a note rather than silently, so the thread still makes sense to read. The error was mine and it was the…
-
Why the timeline is on the right and not the left — what changed since Replied, post #13 · Meta › Site feedback · 30 Mar 2026 · 9 likes This follows post #10 rather than contradicting it. I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The…
-
The "under review" status pill and when a moderator applies it Replied, post #37 · Evidence › Preprints · 25 Mar 2026 · 5 likes I read post #35 twice before replying, because I had assumed the opposite. Two things before anyone answers the substance. First, the context in the first post is clear…
-
Sample handling between despatch and injection Started this topic · Analytics › Method validation · 25 Mar 2026 · 19 likes Sample handling between despatch and injection Writing it up because I had to work it out twice and would rather nobody else did. Posting the method first, because I…
-
Second pass at: Adsorptive losses at low concentration, and why dilute solutions are… Replied, post #69 · Practice › Storage & stability · 21 Mar 2026 · 16 likes Beyond-use dating: the date after which a prepared solution should not be used. It is an estimate based on how fast the solution degrades under stated storage, not on…
-
Splitting a weekly dose in two: the pharmacokinetic argument against Replied, post #15 · Practice › Dosing & titration · 8 Mar 2026 · 0 likes This follows post #12 rather than contradicting it. Dose equivalence between different incretin analogues is a weak concept. The molecules differ in structure,…
-
Adducts: sodium, potassium, and the peak you did not expect — does this still hold? Replied, post #50 · Analytics › Mass spectrometry · 26 Feb 2026 · 0 likes Common adducts: sodium adds ≈22, potassium adds ≈38 compared to hydrogen. A [M+Na]+ peak is common and its mass is predictable from the base mass.
-
Anaesthesia and elective surgery: the aspiration question Replied, post #31 · Practice › Interactions · 24 Feb 2026 · 0 likes Metformin: commonly co-administered and relevant to gastrointestinal tolerability. Gastrointestinal side effects can overlap and additive. Taking them separately or…
-
Why "dose equivalence" between different incretin analogues is a weak concept Replied, post #132 · Practice › Dosing & titration · 22 Feb 2026 · 7 likes Dose equivalence between different incretin analogues is a weak concept. The molecules differ in structure, half-life, receptor selectivity, and in what has been…
-
Managing an unplanned gap in supply Replied, post #17 · Access › Shortages · 29 Jan 2026 · 22 likes Compounding during shortages: some jurisdictions allow pharmacy compounding when a marketed product is in shortage. That permission is jurisdiction-specific and…
-
Personal import allowances, compared — a second dataset Replied, post #58 · Access › International · 26 Jan 2026 · 0 likes On post #54 — agreed on the reasoning, with one qualification. Country-by-country legality: compound approval and legal status differ substantially by jurisdiction.…
-
Reading an interaction checker output critically Replied, post #76 · Practice › Interactions · 26 Dec 2025 · 3 likes Alcohol: no absolute contraindication but it raises gastrointestinal irritation risk and this drug class already does that. The conservative position during titration…
-
Which panel is worth repeating and which is worth ignoring — a second dataset Replied, post #27 · Clinical › Bloodwork · 12 Dec 2025 · 9 likes Picking up post #24: that is the part I would want checked first. Thank you for the correction. I have edited my earlier post with a note rather than silently, so the…
-
[2026 update] Storing lyophilised material long term: what governs the shelf life Replied, post #28 · Practice › Storage & stability · 27 Nov 2025 · 0 likes Refrigeration slows degradation. Repeated warming and cooling is worse than continuous refrigeration. Light exposure is worth avoiding. The concentration matters…
-
Severe gastroparesis and why this class is a poor fit — one year on Replied, post #9 · Safety › Contraindications · 21 Nov 2025 · 7 likes Coming back to post #7, because the follow-up matters more than the original answer. History of pancreatitis: these compounds can rarely trigger pancreatitis. History…
-
[2026 update] Reporting a disappointing outcome, and why it belongs here Started this topic · Outcomes › Progress reports · 18 Nov 2025 · 17 likes On the subject in the title: Reporting a disappointing outcome, and why it belongs here Working notes rather than a conclusion. Longitudinal report with the method…
-
A comparison of home results against a laboratory result on the same vial Replied, post #60 · Analytics › Home & field testing · 8 Nov 2025 · 26 likes Lateral-flow devices: like a rapid COVID test. They have a reagent strip and produce a colour result. They are quick but not precise and not intended for quantitative…
-
Pharmaceutical compounding rules, summarised from primary sources — a second dataset Replied, post #17 · Sourcing › Regulatory · 5 Nov 2025 · 0 likes Worth separating two things that post #13 runs together. Import restrictions vary by compound and by jurisdiction: what is a controlled substance in one place is legal…
-
Tirzepatide molecular mass and the charge states you would expect on ESI — does this… Replied, post #4 · Compounds › Tirzepatide · 16 Oct 2025 · 23 likes On post #3 — agreed on the reasoning, with one qualification. Dual agonism versus dose: how much of tirzepatide's effect is the GIP component and how much is simply…
-
Second pass at: How to ask a question when you cannot say why you are asking it Replied, post #21 · Start Here › How to Ask · 8 Oct 2025 · 0 likes Questions you cannot explain: "I cannot say why I am asking this, but is this compound stable at room temperature?" is more productive than no question at all. People…
-
Meeting a protein target on a suppressed appetite Replied, post #24 · Nutrition & Training › Protein & intake · 26 Sep 2025 · 0 likes For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add the caveats that make it safe to use.
-
Payment method and the leverage it gives you, ranked Replied, post #65 · Sourcing › Payments · 24 Sep 2025 · 0 likes Cryptocurrency for payment: offers less fraud protection than credit cards and is final like bank transfer. Advantage: no geographic restrictions and no intermediary…
-
Hypertension improvement and when medication needs revisiting Replied, post #58 · Clinical › Comorbidities · 13 Sep 2025 · 21 likes Comorbidity control: if a comorbidity (high blood pressure, high lipids) is not adequately controlled, the decision about adding compounds in this class depends on the…
-
Semaglutide versus liraglutide head to head: reading STEP 8 carefully Replied, post #54 · Compounds › Semaglutide · 7 Sep 2025 · 10 likes The STEP programme populations were selected: enrollment criteria required baseline body mass index over 30, no recent blood pressure crisis, no recent retinopathy, no…
-
Tirzepatide molecular mass and the charge states you would expect on ESI Replied, post #33 · Compounds › Tirzepatide · 29 Aug 2025 · 0 likes post #32 is right about the mechanism and I think understates the practical bit. The 2.5 mg starting dose is not a therapeutic dose in the sense that weight loss is…
-
The nausea timeline across the first four weeks, with a tabulated log Replied, post #9 · Practice › Side effects · 22 Aug 2025 · 0 likes Recognition and grading: nausea ranges from "noticeable" to "limiting". Constipation ranges from mild to severe. Having language to describe the magnitude helps you…
-
Coming back to: Oxidation and deamidation mass shifts, tabulated Replied, post #22 · Analytics › Mass spectrometry · 20 Jul 2025 · 9 likes For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add the caveats that make it safe to use.
-
Domestic fridge temperature mapping: a cheap experiment — what changed since Replied, post #141 · Devices › Cold chain · 12 Jul 2025 · 19 likes Light protection: avoid direct sunlight and UV exposure. Amber vials or opaque containers reduce light exposure. For short-term storage, keeping the vial in its…
-
Gauge and length selection for subcutaneous injection Replied, post #8 · Devices › Syringes & needles · 29 Jun 2025 · 0 likes This follows post #5 rather than contradicting it. Needle gauge: smaller numbers (30G) are finer and less painful. Larger numbers (25G) are courser. For subcutaneous…
-
A claim built entirely on a subgroup analysis Replied, post #71 · Evidence › Study critique · 2 Jun 2025 · 13 likes Bias towards the null and bias away from the null: different criticisms have different directions. Differential dropout might bias away from null; conservative…
-
Second pass at: Pen dose counters: what a click does and does not guarantee Replied, post #47 · Devices › Pens & autoinjectors · 23 May 2025 · 3 likes Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did and when. The single most useful thing in your own…
-
A report I filed that turned out to be wrong, and the correction Replied, post #61 · Sourcing › Vendor reports · 19 May 2025 · 17 likes Testing service selection: Janoshik gives purity with chromatogram. Medutest gives combined purity and identity. PeptideMeter gives verification records as well as…
-
Journal club: SURMOUNT-4 and continuation versus withdrawal — a second dataset Replied, post #35 · Evidence › Journal club · 19 May 2025 · 0 likes SURPASS-2 (N Engl J Med 2021): Direct comparison of tirzepatide with semaglutide 1.0 mg. The 1.0 mg dose is not the highest available, which is the central and…
-
Pregnancy as an absolute contraindication Replied, post #74 · Safety › Contraindications · 19 May 2025 · 3 likes Coming back to post #72, because the follow-up matters more than the original answer. Allergy to the specific compound: true allergy is rare but possible. Any prior…
-
A claim built entirely on a subgroup analysis Replied, post #39 · Evidence › Study critique · 17 May 2025 · 13 likes Defending a paper against criticism: if the authors respond, they might clarify something the paper explained poorly. Their response might also miss your point. Either…
-
Criticising the method without criticising the authors Replied, post #62 · Evidence › Study critique · 6 May 2025 · 0 likes post #61 is right about the mechanism and I think understates the practical bit. Defending a paper against criticism: if the authors respond, they might clarify…
-
Asking about a compound your prescriber has not heard of Replied, post #29 · Clinical › Prescriber conversations · 1 May 2025 · 21 likes Worth separating two things that post #25 runs together. How to ask for what you need: rather than "should I take this", frame it as "I understand the evidence for this…
-
Reading a trial's population section before its results — does this still hold? Replied, post #19 · Evidence › Trials · 18 Apr 2025 · 22 likes Dropout is information: high dropout rates can indicate tolerability problems or lower efficacy than the summary suggests. Where the analysis handled dropouts matters.…
-
Carryover and the ghost peak from last week's standard Replied, post #86 · Analytics › HPLC & UHPLC · 11 Apr 2025 · 26 likes Column chemistry and particle size: smaller particles (1.7 μm) give better resolution and higher efficiency than larger particles (3.5 μm or 5 μm), at the cost of…
-
Reading order for a first week here, and what to skip until later Replied, post #65 · Start Here › Welcome · 3 Apr 2025 · 19 likes Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather than quietly editing. The correction was fair and I had…
-
Requesting a translation of an existing page Replied, post #4 · Documentation › Wiki requests · 24 Mar 2025 · 30 likes post #3 answers the question as asked. The question underneath it is different. I disagree with the reply above, and I think the disagreement is substantive rather than…
-
Follow-up: Tesamorelin has an approved indication — what that changes about the evidence Replied, post #30 · Compounds › Secretagogues & GH axis · 24 Mar 2025 · 9 likes Evidence quality in the secretagogue literature is honestly weaker than in the incretin literature. Large randomised controlled trials are rare. Most evidence is…
-
Maintainer handover: how it works Replied, post #76 · Meta › Wiki maintenance · 19 Mar 2025 · 19 likes Cross-referencing: if two pages should reference each other but do not, suggesting the cross-reference helps the maintainer see the connection.
-
What SELECT changed about how semaglutide is discussed, and what it did not Replied, post #44 · Compounds › Semaglutide · 18 Mar 2025 · 8 likes The opalescent appearance in semaglutide solutions is occasionally noted and the mechanism is unclear. It does not appear to correlate with product failure in practice.…
-
Amylin analogue mechanism: satiety signalling separate from GLP-1 Replied, post #79 · Compounds › Cagrilintide & amylin analogues · 11 Mar 2025 · 31 likes For anyone arriving from searches on "amylin agonist": this subcategory discusses published clinical evidence and what it does and does not establish. It does not…
-
Second pass at: Regression to the mean in progress reports Replied, post #68 · Research Methods › Statistics · 26 Feb 2025 · 33 likes This follows post #65 rather than contradicting it. Confounding: a third variable explains an apparent association. In randomised data, randomisation balances…
-
A page that has drifted out of date and needs a maintainer Replied, post #68 · Documentation › Wiki requests · 24 Feb 2025 · 0 likes Coming back to post #66, because the follow-up matters more than the original answer. Request a new maintained page: if a question recurs, has a good marked solution,…
-
A 5 mg vial and a 0.25 mg dose: the arithmetic in full — the long version Replied, post #31 · Practice › Reconstitution · 11 Feb 2025 · 0 likes Two things before anyone answers the substance. First, the context in the first post is clear and specific. Second, the question is framed so that an answer can…
-
Random versus fixed effects: choosing rather than defaulting — a second dataset Replied, post #82 · Evidence › Meta-analyses · 9 Feb 2025 · 0 likes Coming back to post #80, because the follow-up matters more than the original answer. Fixed-effects versus random-effects models: fixed-effects assumes all studies are…
-
Random versus fixed effects: choosing rather than defaulting — a second dataset Replied, post #61 · Evidence › Meta-analyses · 6 Feb 2025 · 1 like post #60 answers the question as asked. The question underneath it is different. Sensitivity analysis: the authors re-run the meta-analysis excluding studies one at a…
-
What changed in 2026, by region Replied, post #105 · Access › International · 28 Jan 2025 · 10 likes On post #101 — agreed on the reasoning, with one qualification. Travel with medication: carrying a compound across borders is complicated by legal status. Documenting…
-
Follow-up: Individual participant data versus aggregate data Replied, post #100 · Evidence › Meta-analyses · 11 Jan 2025 · 10 likes Coming back to post #98, because the follow-up matters more than the original answer. Practical note that does not fit anywhere else. Whatever you conclude from this…
-
Revisiting: Semaglutide formulation: what is in the licensed product besides the peptide Replied, post #59 · Compounds › Semaglutide · 30 Dec 2024 · 0 likes The opalescent appearance in semaglutide solutions is occasionally noted and the mechanism is unclear. It does not appear to correlate with product failure in practice.…
-
Gallbladder disease risk with rapid weight loss Replied, post #49 · Clinical › Comorbidities · 27 Dec 2024 · 2 likes For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add the caveats that make it safe to use.
-
Oral semaglutide bioavailability and its variability between people — a second dataset Replied, post #3 · Compounds › Oral incretins · 24 Dec 2024 · 0 likes PIONEER 6 was a cardiovascular safety trial for oral semaglutide, not an efficacy trial. Non-inferiority for safety was demonstrated. The point estimates favoured the…
-
Body image changing more slowly than the body Replied, post #42 · Wellbeing › Mental health · 15 Dec 2024 · 0 likes post #41 answers the question as asked. The question underneath it is different. Body image and weight loss: large weight loss changes a person's relationship with…
-
Follow-up: Oral contraceptives and delayed emptying: what the data shows Replied, post #29 · Practice › Interactions · 7 Dec 2024 · 0 likes Coming back to post #27, because the follow-up matters more than the original answer. Alcohol: no absolute contraindication but it raises gastrointestinal irritation…
-
EMA product information as a primary source — does this still hold? Replied, post #45 · Regional › European Union · 16 Nov 2024 · 0 likes Worth separating two things that post #41 runs together. EMA is the regulator with national implementation. Licensed incretin analogues are prescription-only across the…
-
Promotion criteria, and the one that stops most nominations Replied, post #90 · Documentation › Doc review · 19 Oct 2024 · 0 likes Revision disputes: if you disagree with an edit a maintainer made to a page, discuss it here. The goal is accuracy and clarity, not authorship.
-
Transit times by route, from a logged dataset — the long version Replied, post #17 · Sourcing › Logistics · 3 Oct 2024 · 12 likes Cold packs and temperature control: inclusion of cold packs at despatch is standard. Whether they maintain temperature through transit depends on journey duration and…
-
Why we hide unevidenced fraud accusations and log the hiding Started this topic · Sourcing › Red flags · 21 Sep 2024 · 1 like Why we hide unevidenced fraud accusations and log the hiding — that is the question, and I have not found it answered plainly anywhere I have looked. I would like to…
-
Correlation in a self-tracked dataset: what it can support Replied, post #119 · Research Methods › Statistics · 24 Aug 2024 · 24 likes Worth separating two things that post #115 runs together. Number needed to treat: how many people need to be treated to prevent one bad outcome or achieve one good…
-
Second pass at: A field-by-field walk through a certificate of analysis Replied, post #15 · Analytics › COA interpretation · 29 Jul 2024 · 22 likes A certificate of analysis is a statement by its issuer that a defined test was performed on a defined lot and produced a defined result. That is all it is, and it is…
-
Where the four-week escalation interval comes from, and what it is not Replied, post #11 · Practice › Dosing & titration · 1 Jun 2024 · 28 likes Holding a dose indefinitely: the trials did not study indefinite holding at a non-maximum dose. The trials escalated to a target and then held that. What happens if you…